DWA
BNTX icon

Dorsey Wright & Associates’s BioNTech BNTX Stock Holding History

Dorsey Wright & Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,117
Closed -$5.96M – 290
2021
Q4 		$5.96M Buy
23,117
+411
+2% +$113K 1.23% 20
2021
Q3 		$6.2M Sell
22,706
-18,826
-45% -$5.98M 1.36% 12
2021
Q2 		$9.3M Buy
41,532
+1,323
+3% +$250K 1.98% 2
2021
Q1 		$4.39K Buy
+40,209
New +$4.27M 0.05% 194

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dorsey Wright & Associates's BNTX Position: Q1 2022 in Review

Dorsey Wright & Associates sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 23,117 shares — an estimated $5.96M sold.

Dorsey Wright & Associates first reported a position in BNTX in Q1 2021 and held it in 4 quarters. The position peaked at $9.3M in Q2 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Dorsey Wright & Associates reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Dorsey Wright & Associates sold 23,117 BioNTech shares in Q1 2022, an estimated $5.96M.
  • Dorsey Wright & Associates first reported a position in BioNTech in Q1 2021 and held it in 4 quarters.
  • Dorsey Wright & Associates's BioNTech position peaked at $9.3M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Dorsey Wright & Associates's 13F filing for Q1 2022, filed 27 Apr 2022.